Acute Q fever revealed by an anti-phospholipid syndrome: A case report

K Balasoupramanien1, J-B Roseau2, N Cazes3

  • 1173rd Medical Unit, 11th Army Medical Centre, 10, rue Roquemaurel, 31032 Toulouse, France.

La Revue De Medecine Interne
|May 18, 2024
PubMed
Abstract

Insights

This case study highlights an unusual presentation of Q fever (Coxiella burnetii infection) revealed by significant pleural effusion and thrombosis. Early screening for Coxiella burnetii and antiphospholipid antibodies is recommended for atypical pneumonia with thrombotic events.

Area of Science:

  • Infectious Diseases
  • Rheumatology
  • Pulmonology

Background:

  • Q fever, a zoonosis caused by Coxiella burnetii, typically presents asymptomatically or with flu-like symptoms, pneumonia, or hepatitis.
  • Atypical presentations, such as massive pleural effusion, are uncommon but possible during acute C. burnetii infections.

Observation:

  • A 43-year-old male presented with acute respiratory distress, diagnosed with exudative eosinophilic pleural effusion, pulmonary embolism, and deep femoral vein thrombosis.
  • Etiologic investigations confirmed acute Q fever and the presence of antiphospholipid antibodies.

Findings:

  • Acute Q fever infection was identified through serological testing for Coxiella burnetii phase II antigens.
  • The patient's condition improved with a treatment regimen including vitamin K antagonists, doxycycline, and hydroxychloroquine, leading to the negativation of antiphospholipid antibodies.

Implications:

  • Antiphospholipid antibodies are prevalent in acute C. burnetii infections, though thrombotic complications are rare.
  • Screening for C. burnetii and antiphospholipid antibodies is valuable in cases of atypical pneumonia and/or thrombotic events.
  • The management of C. burnetii-associated antiphospholipid syndrome requires further research, but a combination of doxycycline, hydroxychloroquine, and anticoagulation proved effective in this case.